You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

16 search results for: biomarkers

The Role of <b>Biomarkers</b> in Clinical Decision-Making in Atopic Dermatitis
expert video

The Role of Biomarkers in Clinical Decision-Making in Atopic Dermatitis

Dermatology
Dr. Stephan Weidinger talks about the role of biomarkers and their impact on clinical decision-making.
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
ADVENT On Air | Role of Type 2 Inflammation in COPD
Podcast

ADVENT On Air | Role of Type 2 Inflammation in COPD

Pulmonology
Drs Stephanie Christenson and Jean Bourbeau explore the role of type 2 inflammation in Chronic Obstructive Pulmonary Disease (COPD).
View more
CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis
Infographic

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

Dermatology
An infographic to explore the the key roles of CCL17 (TARC) in atopic dermatitis.
View more
How Can FeNO Measurement Improve Severe Asthma Management?
expert video

How Can FeNO Measurement Improve Severe Asthma Management?

Pulmonology
Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.
View more
What is the Role of FeNO as an Asthma Biomarker?
expert video

What is the Role of FeNO as an Asthma Biomarker?

Pulmonology
Prof. Klaus Rabe and Dr. Michael Wechsler explore the utility of FeNO as a biomarker in asthma.
View more
Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes
interactivity

Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes

Pulmonology
This infographic outlines how endotyping, phenotyping, and genotyping are interrelated concepts that are crucial for improving the way patients with COPD are characterized and how understanding these concepts can better optimize patient care
View more
New Perspectives on Disease Modification in Atopic Dermatitis - Panel Discussion
expert video

New Perspectives on Disease Modification in Atopic Dermatitis - Panel Discussion

Dermatology
Panel discussion exploring what disease modification could involve in atopic dermatitis.
View more
New Perspectives on Disease Modification in Atopic Dermatitis
expert video

New Perspectives on Disease Modification in Atopic Dermatitis

Dermatology
An exploration into the concept and potential of disease modification through therapeutic interventions in AD.
View more
Exploring The Concept of Disease Modification in Atopic Dermatitis
expert video

Exploring The Concept of Disease Modification in Atopic Dermatitis

Dermatology
Exploring the concept ​of disease modification and related pathomechanisms ​in atopic dermatitis​.
View more
The Impact of Advanced Systemic Therapies on Disease Control and Potential Remission in Atopic Dermatitis
expert video

The Impact of Advanced Systemic Therapies on Disease Control and Potential Remission in Atopic Dermatitis

Dermatology
Exploring the concept ​of disease modification relating to therapeutic interventions with targeted systemic therapies in atopic dermatitis​.
View more
Can Early Intervention Shape the Course of Atopic Dermatitis?
expert video

Can Early Intervention Shape the Course of Atopic Dermatitis?

Dermatology
Exploring the concept ​of disease modification through early intervention with targeted systemic therapies in atopic dermatitis​.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: AlgeriaChange country/region